Charles River Laboratories has extended its longstanding, strategic, drug discovery partnership with Chiesi Farmaceutici SpA in the field of respiratory disease. Under the alliance, Charles River will provide integrated drug discovery services, including medicinal chemistry, ADME/DMPK studies, pharmaceutics, in vitro assays, in vivo models, and safety pharmacology studies to help identify and test Chiesi’s candidates for preclinical development. “Over the past six years, our integrated r...